Recent SYRS Stock Price | SYRS Stock Predictions | |
$5.10 | +277.45% |
$19.25 |
Recent SYRS Analyst Ratings Breakdown, Making SYRS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 5 | 5 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the SYRS stock predictions from the analysts covering Syros Pharmaceuticals Inc, we have collected all of the individual SYRS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering SYRS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since SYRS stock predictions may vary widely, another useful metric to consider is the median SYRS stock prediction, which represents the price at which half of the analysts
made SYRS stock predictions that were higher and half made SYRS stock predictions that were lower. This makes for a different take on the SYRS stock predictions out there, as compared to average or mean.
And that median across all the individual SYRS stock predictions was: $14.0 as of 2024-04-26.
The very highest of the SYRS stock predictions for one year price target was $37.0, while the very lowest of the SYRS stock predictions in the analyst group was
$12.0 (with a standard deviation of $11.898). Get the latest Zacks research report on SYRS — FREE
Find out: SYRS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
TRV Stock Predictions
KLDO Stock Predictions
G Stock Predictions
SPFI Stock Predictions
CCC Stock Predictions
X Stock Predictions
MEDP Stock Predictions
PPL Stock Predictions
CALA Stock Predictions
|
|
Strong Buy (4.00 out of 4) 80th percentile
(ranked higher than approx. 80% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |